Cyclin E2 Antikörper
Kurzübersicht für Cyclin E2 Antikörper (ABIN1112804)
Target
Alle Cyclin E2 (CCNE2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
- 
    - 
                                            Immunogen
- A synthetic peptide (conjugated with KLH) corresponding to the C-terminal of Cyclin E2.
- 
                                            Isotyp
- IgG1
 
- 
                                            
- 
    
- 
    - 
                                            Applikationshinweise
- WB (1:5000). Other applications have not been tested. The optimal dilutions should be determined by end user.
- 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Buffer
- TBS (pH7.4), 0.5% BSA, 25% Glycerol and 0.05% Sodium Azide.
- 
                                            Konservierungsmittel
- Sodium azide, Thimerosal (Merthiolate)
- 
                                            Lagerung
- 4 °C/-20 °C
- 
                                            Informationen zur Lagerung
- Store at 4 °C after thawing (1 week). Aliquot and store at -20 °C for long term (at least one year). Avoid repeated freeze and thaw cycles.
- 
                                            Haltbarkeit
- 12 months
 
- 
                                            
- 
    - Cyclin E2 (CCNE2)
- 
                                            Andere Bezeichnung
- Cyclin E2
- 
                                            Hintergrund
- Cyclin E2 is a member of the cyclin family, It is a predicted 404-amino acid protein which contains a cyclin box motif and it is 47% identical to cyclin E1. It is expressed in several normal human tissues, with the highest levels in testis, thymus, and brain. Gudas et al. (1999) found that, like cyclin E1, the human cyclin E2 gene complemented a G1 cyclin defect in S. cerevisiae. Cyclin E2 expressed in mammalian cells associated with CDK2 in a functional kinase complex that was inhibited by both KIP1 and CIP1.
- 
                                            Pathways
- Zellzyklus, Mitotic G1-G1/S Phases
 Target
- 
                    
 
                                     
                                     
                                    